G

Galderma Group AG
F:PY30

Watchlist Manager
Galderma Group AG
F:PY30
Watchlist
Price: 36.4 EUR 2.25% Market Closed
Market Cap: €8.6B

Wall St Price Targets

PY30 Price Targets Summary
Galderma Group AG

Wall Street analysts forecast PY30 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PY30 is 41 EUR with a low forecast of 32.6 EUR and a high forecast of 58.45 EUR.

Lowest Forecast
Price Target
32.6 EUR
10% Downside
Average Forecast
Price Target
41 EUR
13% Upside
Highest Forecast
Price Target
58.45 EUR
61% Upside
Galderma Group AG Competitors:
Price Targets
ELCO
Eleco PLC
83% Upside

Revenue
Forecast

11% / Year
Past Growth
18% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
11% / Year
Past Growth
18% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 18%.

Gross Profit
Forecast

11% / Year
Past Growth
19% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
11% / Year
Past Growth
19% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 19%.

Operating Income
Forecast

30% / Year
Past Growth
37% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
30% / Year
Past Growth
37% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Operating Income has been 30%. The projected CAGR for the next 3 years is 37%.

Pre-Tax Income
Forecast

N/A
Past Growth
55% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
55% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 55%.

Net Income
Forecast

N/A
Past Growth
47% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
47% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Net Income over the next 3 years is 47%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PY30's stock price target?
Price Target
41 EUR

According to Wall Street analysts, the average 1-year price target for PY30 is 41 EUR with a low forecast of 32.6 EUR and a high forecast of 58.45 EUR.

What is the Revenue forecast for Galderma Group AG?
Projected CAGR
18%

Over the last 3 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 18%.

What is the Gross Profit forecast for Galderma Group AG?
Projected CAGR
19%

Over the last 3 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 19%.

What is the Operating Income forecast for Galderma Group AG?
Projected CAGR
37%

Over the last 3 years, the compound annual growth rate for Operating Income has been 30%. The projected CAGR for the next 3 years is 37%.

What is the Pre-Tax Income forecast for Galderma Group AG?
Projected CAGR
55%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 55%.

What is the Net Income forecast for Galderma Group AG?
Projected CAGR
47%

The compound annual growth rate for Net Income over the next 3 years is 47%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett